CEO Message

CEO Message

Better Medicine for a Brighter Tomorrow Better Medicine for a Brighter Tomorrow

Solasia was founded to develop innovative drugs specializing in oncology field and bring them into Japan and other Asian countries.

We have five product pipelines with our aspiration to deliver better medicines to the patients. Two products were completed the clinical development, approved by the authorities, and launched as well. One product was completed the pivotal clinical study and filed a new drug application to the authority. Furthermore, one product is being conducted the Phase III clinical study.
Our mission, as our company name stand for, is to be the Sun brightening the future for the patients facing the challenges of cancers.

All of us at Solasia continue to challenge and grow further and strive to introduce, develop and provide better treatment options for patients suffering from cancer.
Your understanding and continuous support to Solasia would be highly appreciated.

July 2021
Yoshihiro Arai
President and Chief Executive Officer